Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001655759-23-000093
Filing Date
2023-11-07
Accepted
2023-11-07 16:27:40
Documents
76
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arvn-20230930.htm   iXBRL 10-Q 945901
2 EX-31.1 arvn-20230930x10qex311.htm EX-31.1 10292
3 EX-31.2 arvn-20230930x10qex312.htm EX-31.2 10456
4 EX-32.1 arvn-20230930x10qex321.htm EX-32.1 5024
5 EX-32.2 arvn-20230930x10qex322.htm EX-32.2 4854
  Complete submission text file 0001655759-23-000093.txt   5999487

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20230930.xsd EX-101.SCH 47700
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arvn-20230930_cal.xml EX-101.CAL 61222
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arvn-20230930_def.xml EX-101.DEF 201763
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20230930_lab.xml EX-101.LAB 653521
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20230930_pre.xml EX-101.PRE 410029
70 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20230930_htm.xml XML 733032
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38672 | Film No.: 231384346
SIC: 2834 Pharmaceutical Preparations